1. Rituximab in the treatment of pembrolizumab-induced myasthenia gravis. (October 2018) Authors: Crusz, S.M.; Radunovic, A.; Shepherd, S.; Shah, S.; Newey, V.; Phillips, M.; Lim, L.; Powles, T.; Szlosarek, P.W.; Shamash, J.; Rashid, S. Journal: European journal of cancer Issue: Volume 102(2018) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗